SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-16-096578
Filing Date
2016-02-12
Accepted
2016-02-12 16:01:37
Documents
2
Group Members
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D a16-4274_1sc13d.htm SC 13D 232350
2 EX-1 a16-4274_1ex1.htm EX-1 14113
  Complete submission text file 0001104659-16-096578.txt   248268
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD RESEARCH CORP (Subject) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D | Act: 34 | File No.: 005-48710 | Film No.: 161418747
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations